HUMAN MATERIAL TRANSFER AGREEMENT FOR RESEARCH PURPOSEHuman Material Transfer Agreement • September 6th, 2023
This Human Material Transfer Agreement (the “Agreement”) is entered into and made effective as of latest date of signature below (the “Effective Date”) by and between:
CHEAR Human Material Transfer AgreementHuman Material Transfer Agreement • September 9th, 2016
A Material Transfer Agreement (MTA) is a contract that governs the transfer of tangible research materials between two organizations, when the recipient intends to use it for his or her own research purposes. An MTA defines the rights of the provider and the recipient with respect to the materials and any derivatives.1
HUMAN MATERIAL TRANSFER AGREEMENT FOR RESEARCH PURPOSEHuman Material Transfer Agreement • June 27th, 2018
This Human Material Transfer Agreement (the “Agreement”) is entered into and made effective as of latest date of signature below (the “Effective Date”) by and between:
HUMAN MATERIAL TRANSFER AGREEMENTHuman Material Transfer Agreement • January 11th, 2023
This Human Material Transfer Agreement ("MTA") is between University of Foggia – Department of Medical and Surgical Sciences having a principal address at Via Gramsci no. 89/91 - 71122 Foggia - Italy and operational headquarters in Via L. Pinto n. 1 - 71122 Foggia - Italy (“PROVIDER”), and Icahn School of Medicine at Mount Sinai, a New York not-for-profit education corporation having an office at One Gustave L. Levy Place, New York, NY 10029 - Mount Sinai (“RECIPIENT”), for the transfer of human material, with or without accompanying data, for research purposes as further defined below. PROVIDER and RECIPIENT may each be referred to as Party or collectively as Parties. This MTA will become effective on the date of the last signature below and shall expire on the termination of the Research Project.
Human Material Transfer Agreement (HMTA)Human Material Transfer Agreement • August 28th, 2019
<Names of CIMACs who will receive the Biospecimens> (collectively “Recipient CIMACs”) will be receiving the biospecimens as specified in Appendix A of this Agreement; and the data related to the biospecimens will be provided to Dana-Farber Cancer Institute, Inc. (the “CIDC”), and may be accessed, as described below, by Leland Stanford Junior University, the University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute, Inc., and the Icahn School of Medicine at Mount Sinai (“the CIMACs”). The CIMACs and CIDC are jointly the “Recipients”. Each Recipient and the Provider is hereafter individually referred to as a “Party” and jointly as the “Parties”. This Agreement is effective as of the date of last signature of an authorized representative of a Party below (“Effective Date”).
Human Material Transfer Agreement (HMTA)Human Material Transfer Agreement • May 30th, 2019
The purpose of this Human Material Transfer Agreement (“Agreement”) is to transfer NCI- sponsored clinical trial biospecimens and associated data from the “Provider” (identified on the Signature Page), to one or more of: Dana-Farber Cancer Institute, Inc., Leland Stanford Junior University, the University of Texas MD Anderson Cancer Center, and the Icahn School of Medicine at Mount Sinai (each a “CIMAC”); and data related to the biospecimens to Dana- Farber Cancer Institute, Inc. (the “CIDC”), (all jointly the “Recipients”). Each Recipient and the Provider is hereafter individually referred to as a “Party” and jointly as the “Parties”. This Agreement is effective as of the date of Provider’s authorized signature below (“Effective Date”).
Human Material Transfer Agreement (HMTA)Human Material Transfer Agreement • September 6th, 2023
The purpose of this Human Material Transfer Agreement (“Agreement”) is to transfer National Cancer Institute (NCI)-sponsored clinical trial biospecimens and associated data from “Provider”, listed below, to collaborate with the CIMAC-CIDC on correlative studies as described in the Research Projects (defined below) for the Protocols identified in the Exhibits attached to this Agreement.
HUMAN MATERIAL TRANSFER AGREEMENTHuman Material Transfer Agreement • December 23rd, 2022
This Human Material Transfer Agreement ("MTA") is between University of Foggia – Department of Medical and Surgical Sciences having a principal address at Via Gramsci no. 89/91 - 71122 Foggia - Italy and operational headquarters in Via L. Pinto n. 1 - 71122 Foggia - Italy (“PROVIDER”), and Icahn School of Medicine at Mount Sinai, a New York not-for-profit education corporation having an office at One Gustave L. Levy Place, New York, NY 10029 - Mount Sinai (“RECIPIENT”), for the transfer of human material, with or without accompanying data, for research purposes as further defined below. PROVIDER and RECIPIENT may each be referred to as Party or collectively as Parties. This MTA will become effective on the date of the last signature below and shall expire on the termination of the Rresearch Pproject.
MUTUAL MATERIAL TRANSFER AGREEMENT FOR THE TRANSFER OF HUMAN MATERIALS FOR RESEARCH PURPOSESHuman Material Transfer Agreement • November 21st, 2022
This Human Material Transfer Agreement ("Agreement") is between University of Cincinnati, a state institution of higher education organized under Chapter 3361 of the Ohio Revised Code (“UC”), and ___________________________ (“Collaborator”), for the transfer of material isolated from individuals who have or will participate in clinical research (each a “Human Subject”), with or without accompanying data, to be used for research purposes as further defined below. Provider and Recipient may each be referred to as a Party or collectively as Parties. This Agreement will become effective on the date of the last authorized signature below (“Effective Date”).
OUTGOING HUMAN MATERIAL TRANSFER AGREEMENTHuman Material Transfer Agreement • June 29th, 2012
This Human Material Transfer Agreement for the transfer of human biological materials (“Agreement”) is made and entered into as of , 201_ (the “Effective Date”), by and between The Chordoma Foundation having offices at 512 S. Mangum Street, 1st Floor, Durham, NC 27701 (“Recipient”), and [specify entity], with offices at
